Material Insights · Understanding the Material World

Combination antiretroviral therapy: Overview

What it does

The job the technology does for people, in a short paragraph

Antiretroviral therapy keeps HIV, the virus that causes AIDS, from multiplying in the body. It does not cure the infection [6], but it lets people live long, healthy lives. The first drug was approved in 1987 and lasting combination treatment arrived in 1996 [1]. In 2025, 32.1 million people, 78% of everyone living with HIV, were receiving it [2].

as of 2026-11-11

How it works

The working principle in plain words, step by step

HIV carries its genes as RNA. Inside a human immune cell it uses its own enzyme, reverse transcriptase, to copy that RNA into DNA, then another enzyme, integrase, to splice the DNA into the cell's genome. The cell then makes new virus parts, which a third enzyme, protease, cuts into working form. Each class of antiretroviral drug blocks one of these steps [1]. HIV copies itself carelessly, so variants that resist any single drug soon appear. Using drugs from two or more classes at once means a variant would need several changes together to escape, which is very unlikely. That is why combinations hold the virus down for years [1].

as of 2026-11-11

Key figures

The handful of numbers that size it up, each with its unit, year and source

FigureValueUnitYearSource
People receiving antiretroviral therapy32.1million people2025[2]
Share of people living with HIV on treatment78%2025[2]
Share of people living with HIV who are virally suppressed74%2025[2]
Fall in AIDS-related deaths since the 2004 peak73%2025[2]
Antiretroviral drugs available, more than (NIAID page, undated)30drugs– [1]

as of 2026-11-11. UNAIDS figures are estimates with ranges (32.1 million: 28.2 to 33.4 million) [2]. The NIAID page gives no date, so the count of drugs carries no year [1].

Where it is used

The main places and products the technology is found in

  • Lifelong treatment of people living with HIV
  • Preventing transmission from mother to child
  • National HIV programmes in low- and middle-income countries
  • HIV clinics and primary care
  • Prevention for people at high risk of infection

as of 2026-11-11

Scale today

How much of it there is now: units in use, made each year and who uses it

Users
32.1 million people on treatment [2]
Unit
people
Year
2025
Note
Of 41.0 million people living with HIV in 2025 [2].

as of 2026-11-11

Sources

  1. Antiretroviral Drug Discovery and Development National Institute of Allergy and Infectious Diseases (NIH)
  2. Fact sheet 2026 UNAIDS, 2026
  3. HIV and AIDS (fact sheet) World Health Organization, 2026